Announcement
17 Mar 2020
In March 2020, the USTR announced a set of exclusions from the additional tariffs on a number of medical products from China.
Source
Number of interventions
1
0 certainly harmful
0 likely harmful
1 liberalising
Implementation date
01 Sep 2019
Revocation date:
30 Nov 2021
On 17 March 2020, the United States Trade Representative (USTR) announced a set of exclusions from the additional 7.5% tariff on a number of medical products from China. The decision is taken in re...
24 Oct 2025
United States of America: Initiation of Section 301 Investigation into China’s Implementation of the Phase One Agreement
28 Mar 2022
United States of America: US Administration provides temporary exclusions on Section 301 tariffs from China (extended until November 2026)
29 Dec 2020
United States of America: USTR excludes medical products from China Section 301 Tariffs
16 Mar 2020
United States of America: Product exclusions from China Section 301 Tariffs
14 Aug 2017
United States of America: Retaliation against China for intellectual property practices
See all
This state act is not part of any Thread yet.